ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

INO Inovio Pharmaceuticals Inc New

9.09
-0.36 (-3.81%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Inovio Pharmaceuticals Inc New INO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.36 -3.81% 9.09 23:00:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.45 9.01 9.45 9.09 9.45
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/6/202407:00PRNUSINOVIO to Participate in Virtual Fireside Chat Hosted by..
31/5/202415:48PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
28/5/202415:01EDGAR2Form 8-K - Current report
22/5/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:10EDGAR2Form 8-K - Current report
13/5/202415:05PRNUSINOVIO Reports First Quarter 2024 Financial Results and..
13/5/202415:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/5/202407:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
29/4/202407:00PRNUSINOVIO to Report First Quarter 2024 Financial Results on May..
15/4/202417:39PRNUSINOVIO Announces Pricing of Approximately $36 Million..
26/3/202417:28PRNUSINOVIO to Participate in The Citizens JMP Novel Therapeutics..
06/3/202415:05PRNUSINOVIO Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202406:00PRNUSGeneos Therapeutics to Present New Clinical Data on..
06/3/202405:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
21/2/202407:00PRNUSINOVIO to Report Fourth Quarter and Year-End 2023 Financial..
07/2/202410:46PRNUSINOVIO to Present at the Oppenheimer 34th Annual Healthcare..
02/2/202407:00PRNUSINOVIO Reports Inducement Grant Under Inducement Plan
31/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
26/1/202415:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
25/1/202415:02EDGAR2Form 8-K - Current report
23/1/202407:00PRNUSINOVIO Announces Effective Date of 1-for-12 Reverse Stock..
22/1/202407:00PRNUSINOVIO to Participate in Virtual Fireside Chat on the..
12/1/202416:27EDGAR2Form 8-K - Current report
04/1/202407:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
03/1/202407:00PRNUSINOVIO Plans to Submit a BLA for INO-3107 as a Potential..
28/11/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202315:00EDGAR2Form PRE 14A - Other preliminary proxy statements
09/11/202315:35EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202315:15EDGAR2Form 8-K - Current report
09/11/202315:05PRNUSINOVIO Reports Third Quarter 2023 Financial Results and..
09/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente